Timely completion and passage of FDA user fee reauthorization legislation is a crucial next step toward helping Americans in need.
BPC applauds FDA’s efforts to incorporate enhancements to accelerate the development and delivery of safe and effective treatments and cures to patients.
Improving Patient Safety and Information Technology Calls for Greater Leadership, Collaboration, and a Systems-Based Approach
BPC’s new report outlines recommendations for improving health IT’s role in providing safer care for patients while promoting innovation.
User fees play a critical role in providing the FDA the resources it needs to maintain the gold standard in both the review and approval of drugs
The legislation will advance groundbreaking medical innovation and research that will help millions of Americans with life-threatening diseases.
Real world data can play a critical role in strengthening the evidence for both the safety and effectiveness of treatments across the drug development life cycle.